Safety and feasibility of the Lung Volume Reduction Reverser (LVR-R) System in patients with severe emphysema – a first-in-human pilot study

In this severely diseased and small patient cohort, LVR-R implantation was technically feasible. Complication rate was similar to other coil studies and requires a careful pre-procedure benefit-risk evaluation. Two of fourteen bilaterally treated individuals demonstrated a notable improvement in lung function.